Isofol Medical, developer of the drug candidate arfolitixorin, has appointed Roger Tell to the position of acting CEO for the company, effective immediately. He succeeds Thomas Andersson, who is leaving…
Isofol Medical, developer of the drug candidate arfolitixorin, has appointed Roger Tell to the position of acting CEO for the company, effective immediately. He succeeds Thomas Andersson, who is leaving…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


